ViewRay’s $59 Million Direct-Registered Equity Offering

Davis Polk advised ViewRay, Inc. in a direct-registered offering of 7,090,581 shares of ViewRay’s common stock and 1,418,116 warrants to purchase shares of ViewRay’s common stock for proceeds to ViewRay of approximately $59 million.

ViewRay’s common stock is listed on the NASDAQ Global Market under the symbol “VRAY.”

Headquartered in Oakwood Village, Ohio, ViewRay designs, manufactures and markets the first and only MRI-guided radiation therapy system that simultaneously images and treats cancer patients, called MRIdian. The company, led by Chris A Raanes, Ajay Bansal and Douglas H Keare, in 2017 recorded $22.2 Million Revenues.

The Davis Polk capital markets team included partner Alan F. Denenberg (Picture) and associates Jeffrey C. Lau, Amy Tu and Dylan Service.

Involved fees earner: Alan Denenberg – Davis Polk & Wardwell; Jeffrey Lau – Davis Polk & Wardwell; Amy Tu – Davis Polk & Wardwell; Dylan Service – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: ViewRay Inc.;


Author: Ambrogio Visconti